Page 70 - Prostate News Today

When men facing problems with BPH put Dr G on the spot for solution.

Data from a new study published in NEJM Evidence shows promise for personalized use of short-term ADT in men with predominantly intermediate-risk prostate cancer.

A new study shows that an artificial intelligence (AI) model co-developed by researchers in the UCLA Jonsson Comprehensive Cancer Center and department of Urology at UCLA can help doctors determine the extent of cancer within the prostate.

By monitoring early-response biomarkers in men undergoing 177Lu-PSMA prostate cancer treatment, physicians can personalize dosing intervals, significantly improving patient outcomes.

That was the model that we collaborated on... adityas team worked with doctors at addenbrookes hospital in cambridge, who further trained and evaluated their code on real patients — including frank, who was diagnosed with prostate cancer. the people who are looking at this stuff all day long must get quite tired. whereas a computer, it doesnt get tired, itjust keeps doing it. how did it feel to be part of something like that? to be part of a trial? a privilege, i suppose. yeah, a privilege. do...

Preferred to start with the work of the ai than even the work. of their consultant colleagues, which is quite interesting. - the ai is consistent. it doesnt get tired or have its own way of doing things, and raj and his team are now about to give their programme for prostate and head and neck cancer to a manufacturer, which will ultimately allow any nhs trust to access the technology. this is the first time an ai programme developed within the nhs will be released as a medical imaging device. th...

The people who are looking at this stuff all day long must get quite tired. whereas a computer, it doesnt get tired, itjust keeps doing it. how did it feel to be part of something like that? to be part of a trial? a privilege, i suppose. yeah, a privilege. doctors still check and sign off the als work, but in tests, they found two thirds of the time, medics didnt feel the need to make any changes. actually, what we found - is that our consultant colleagues preferred to start with the work of the...

And what weve agreed _ with the manufacturer is effectively that the nhs will be able to deploy these models at cost. _ those involved believe this could bejust the beginning for al in health care. kate lambert, bbc news. we just stall oncologist garage, leading in treating patients for head neck and prostate cancers. thanks so much for coming on the programme. thanks so much for coming on the programme-— thanks so much for coming on the rouramme. ., ~ i. ., ., programme. thank you for having ...

And raj and his team are now about to give their programme for prostate and head and neck cancer to a manufacturer, which will ultimately allow any nhs trust to access the technology. this is the first time an ai programme developed within the nhs will be released as a medical imaging device. these hospitals expect to reduce treatment times for their patients. i think its fantastic that were able to do this. and what weve agreed _ with the manufacturer is effectively that the nhs will be able to...

A new study published in the US medical journal ‘The Annals of Internal Medicine’ makes a very strong case for universal genetic testing at the age of 30.